Article Editorial. (2016). New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer). Столичная издательская компания.
Chicago Style (17th ed.) CitationArticle Editorial. New Data from Clinical Practice Again Confirmed the High Efficacy and a Favorable Safety Profile of the Drug Xarelto® in Patients with Atrial Fibrillation (Press Release of the Company Bayer). Столичная издательская компания, 2016.
MLA (9th ed.) CitationArticle Editorial. New Data from Clinical Practice Again Confirmed the High Efficacy and a Favorable Safety Profile of the Drug Xarelto® in Patients with Atrial Fibrillation (Press Release of the Company Bayer). Столичная издательская компания, 2016.